Panes J - Search Results

1

Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose "escalation" in patients losing response.

Chaparro M, Panes J, García V, Mañosa M, Esteve M, Merino O, Andreu M, Gutierrez A, Gomollón F, Cabriada JL, Montoro MA, Mendoza JL, Nos P, Gisbert JP. Chaparro M, et al. Among authors: panes j. J Clin Gastroenterol. 2011 Feb;45(2):113-8. doi: 10.1097/MCG.0b013e3181ebaef9. J Clin Gastroenterol. 2011. PMID: 21242747

2

Evaluation of 5 versus 10 granulocyteaphaeresis sessions in steroid-dependent ulcerative colitis: a pilot, prospective, multicenter, randomized study.

Ricart E, Esteve M, Andreu M, Casellas F, Monfort D, Sans M, Oudovenko N, Lafuente R, Panes J. Ricart E, et al. Among authors: panes j. World J Gastroenterol. 2007 Apr 21;13(15):2193-7. doi: 10.3748/wjg.v13.i15.2193. World J Gastroenterol. 2007. PMID: 17465500 Free PMC article. Clinical Trial.

3

Crohn's disease: a review of current treatment with a focus on biologics.

Panés J, Gomollón F, Taxonera C, Hinojosa J, Clofent J, Nos P. Panés J, et al. Drugs. 2007;67(17):2511-37. doi: 10.2165/00003495-200767170-00005. Drugs. 2007. PMID: 18034589 Review.

4

Are we giving biologics too late? The case for early versus late use.

Ricart E, García-Bosch O, Ordás I, Panés J. Ricart E, et al. Among authors: panes j. World J Gastroenterol. 2008 Sep 28;14(36):5523-7. doi: 10.3748/wjg.14.5523. World J Gastroenterol. 2008. PMID: 18810770 Free PMC article. Review.

5

Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study.

Loras C, Saro C, Gonzalez-Huix F, Mínguez M, Merino O, Gisbert JP, Barrio J, Bernal A, Gutiérrez A, Piqueras M, Calvet X, Andreu M, Abad A, Ginard D, Bujanda L, Panés J, Torres M, Fernández-Bañares F, Viver JM, Esteve M; GETECCu (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa). Loras C, et al. Among authors: panes j. Am J Gastroenterol. 2009 Jan;104(1):57-63. doi: 10.1038/ajg.2008.4. Am J Gastroenterol. 2009. PMID: 19098850

6

Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review.

Gisbert JP, Panés J. Gisbert JP, et al. Among authors: panes j. Am J Gastroenterol. 2009 Mar;104(3):760-7. doi: 10.1038/ajg.2008.88. Epub 2009 Jan 27. Am J Gastroenterol. 2009. PMID: 19174781 Review.

7

[Scientific publication, bibliometric indicators, and Hirsch's h-index].

Gisbert JP, Panés J. Gisbert JP, et al. Among authors: panes j. Gastroenterol Hepatol. 2009 Mar;32(3):140-9. doi: 10.1016/j.gastrohep.2008.09.024. Epub 2009 Feb 20. Gastroenterol Hepatol. 2009. PMID: 19231032 Spanish. No abstract available.

8

[The Hirsch's h-index: a new tool for measuring scientific production].

Gisbert JP, Panés J. Gisbert JP, et al. Among authors: panes j. Cir Esp. 2009 Oct;86(4):193-5. doi: 10.1016/j.ciresp.2009.05.007. Epub 2009 Jul 29. Cir Esp. 2009. PMID: 19643397 Spanish. No abstract available.

9

Optimizing care of hereditary hemorrhagic telangiectasia.

Panés J, Gisbert JP. Panés J, et al. Gastroenterology. 2010 May;138(5):2014-6. doi: 10.1053/j.gastro.2010.03.019. Epub 2010 Mar 19. Gastroenterology. 2010. PMID: 20303966 No abstract available.

10

Stem cell treatment for Crohn's disease.

Panés J, Ordás I, Ricart E. Panés J, et al. Expert Rev Clin Immunol. 2010 Jul;6(4):597-605. doi: 10.1586/eci.10.27. Expert Rev Clin Immunol. 2010. PMID: 20594133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

487 results

Search Page

Filters